1. Home
  2. CGBD vs TNDM Comparison

CGBD vs TNDM Comparison

Compare CGBD & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGBD
  • TNDM
  • Stock Information
  • Founded
  • CGBD 2012
  • TNDM 2006
  • Country
  • CGBD United States
  • TNDM United States
  • Employees
  • CGBD N/A
  • TNDM N/A
  • Industry
  • CGBD Finance: Consumer Services
  • TNDM Medical/Dental Instruments
  • Sector
  • CGBD Finance
  • TNDM Health Care
  • Exchange
  • CGBD Nasdaq
  • TNDM Nasdaq
  • Market Cap
  • CGBD 1.0B
  • TNDM 1.1B
  • IPO Year
  • CGBD 2017
  • TNDM 2013
  • Fundamental
  • Price
  • CGBD $13.69
  • TNDM $10.66
  • Analyst Decision
  • CGBD Hold
  • TNDM Buy
  • Analyst Count
  • CGBD 5
  • TNDM 15
  • Target Price
  • CGBD $14.63
  • TNDM $23.56
  • AVG Volume (30 Days)
  • CGBD 493.0K
  • TNDM 2.6M
  • Earning Date
  • CGBD 08-05-2025
  • TNDM 08-06-2025
  • Dividend Yield
  • CGBD 12.45%
  • TNDM N/A
  • EPS Growth
  • CGBD N/A
  • TNDM N/A
  • EPS
  • CGBD 1.14
  • TNDM N/A
  • Revenue
  • CGBD $234,464,000.00
  • TNDM $1,001,719,000.00
  • Revenue This Year
  • CGBD $14.27
  • TNDM $8.91
  • Revenue Next Year
  • CGBD $5.97
  • TNDM $10.94
  • P/E Ratio
  • CGBD $11.94
  • TNDM N/A
  • Revenue Growth
  • CGBD N/A
  • TNDM 25.84
  • 52 Week Low
  • CGBD $13.12
  • TNDM $9.98
  • 52 Week High
  • CGBD $18.64
  • TNDM $47.60
  • Technical
  • Relative Strength Index (RSI)
  • CGBD 44.58
  • TNDM 26.77
  • Support Level
  • CGBD $13.69
  • TNDM $10.00
  • Resistance Level
  • CGBD $13.85
  • TNDM $11.82
  • Average True Range (ATR)
  • CGBD 0.27
  • TNDM 0.93
  • MACD
  • CGBD -0.01
  • TNDM -0.37
  • Stochastic Oscillator
  • CGBD 34.44
  • TNDM 9.43

About CGBD Carlyle Secured Lending Inc.

Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.

About TNDM Tandem Diabetes Care Inc.

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.

Share on Social Networks: